Welcome to the 41st edition, featuring a Doppler study that confirms a reduction in cerebral blood flow in ME/CFS patients & an Australian study that looks at the levels of parasympathetic activity during sleep. Read more
Welcome to the 40th edition, featuring an American metabolomics study of patient plasma and a study looking at the prevalence of paediatric ME/CFS in Chicago according to diverse community-based random sample. Read more
Welcome to the 39th edition, featuring a systematic review of ME/CFS randomized controlled trials and a study into the use of heart rate variability as a non-invasive biomarker for predicting fatigue severity in ME/CFS patients. Read more
Welcome to the 38th edition, featuring a Nature paper examining blood lactate levels in ME/CFS patients whilst at rest and a paper investigating the effect of pharmaceutical intervention on NK cell cytotoxicity in ME/CFS patients compared to healthy individuals. Read more
Welcome to the 37th edition, featuring a retrospective study on the effectiveness of using low-dose naltrexone on ME/CFS patients, and a meta-analysis comparing protein biomarkers of inflammation between ME/CFS patients and non-affected controls. Read more
Welcome to the 36th edition, featuring research looking at altered cardiac autonomic regulation in ME/CFS patients, an analysis of risk factors for ME/CFS and a systematic review of natural killer cells and cytotoxic function in ME/CFS. Read more
Welcome to the 35th edition, featuring an article that examines the results of the controversial PACE trial and offers an alternative clinical approach for practitioners working with patients with ME/CFS, and a paper from NCNED suggesting a potential pharmaco-therapeutic intervention for ME/CFS. Read more
Welcome to the 34th edition, featuring an editorial on the advances in ME/CFS research and clinical care, and a Cochrane amended review of the effectiveness of graded exercise therapy. Read more
The 2017 Cochrane review of exercise therapy was the subject of a serious complaint which highlighted flaws in its methodology and the methodology of the studies which it reviewed. Cochrane has been working with the review authors to deal with the complaint for over a year. It has now published an update of the review. Read more